{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T14:45:34Z","timestamp":1694875534851},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1507\/endocrj.ej17-0426","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T17:21:56Z","timestamp":1520616116000},"page":"587-592","source":"Crossref","is-referenced-by-count":6,"title":["False-positive TSH receptor antibody\u2014a pitfall of third-generation TSH receptor antibody measurements in neonates\u2014"],"prefix":"10.1507","volume":"65","author":[{"given":"Michiko","family":"Wada","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kita","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tagami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"},{"name":"Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Satoh-\u200dAsahara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Preemptive Medicine and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bucci I, Giuliani C, Napolitano G (2017) Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne) 8: 137.","DOI":"10.3389\/fendo.2017.00137"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Balucan FS, Morshed SA, Davies TF (2013) Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance. J Thyroid Res 2013: 182472.","DOI":"10.1155\/2013\/182472"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Cooper DS, Laurberg P (2013) Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 1: 238\u2013249.","DOI":"10.1016\/S2213-8587(13)70086-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kamijo K (2007) TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves\u2019 disease. Endocr J 54: 619\u2013624.","DOI":"10.1507\/endocrj.K06-196"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 van der Kaay DC, Wasserman JD, Palmert MR (2016) Management of neonates born to mothers with Graves\u2019 disease. Pediatrics 137: e20151878.","DOI":"10.1542\/peds.2015-1878"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, et al. (2012) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97: 2543\u20132565.","DOI":"10.1210\/jc.2011-2803"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8 Besancon A, Beltrand J, Le Gac I, Luton D, Polak M (2014) Management of neonates born to women with Graves\u2019 disease: a cohort study. Eur J Endocrinol 170: 855\u2013862.","DOI":"10.1530\/EJE-13-0994"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9 Hamada N, Momotani N, Ishikawa N, Yoshimura Noh J, Okamoto Y, et al. (2011) Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism. Endocr J 58: 55\u201358.","DOI":"10.1507\/endocrj.K10E-123"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10 Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, et al. (2005) Management of Graves\u2019 disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90: 6093\u20136098.","DOI":"10.1210\/jc.2004-2555"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Bj\u00f8rgaas MR, Farstad H, Christiansen SC, Blaas HG (2013) Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves\u2019 disease. Horm Res Paediatr 79: 39\u201343.","DOI":"10.1159\/000342644"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Besan\u00e7on A, Beltrand J, Le Gac I, Luton D, Polak M (2014) Management of neonates born to women with Graves\u2019 disease: a cohort study. Eur J Endocrinol 170: 855\u2013862.","DOI":"10.1530\/EJE-13-0994"},{"key":"12","doi-asserted-by":"publisher","unstructured":"13 Smith BR, Bolton J, Young S, Collyer A, Weeden A, et al. (2004) A new assay for thyrotropin receptor autoantibodies. Thyroid 14: 830\u2013835.","DOI":"10.1089\/1050725042451248"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Besan\u00e7on A, Beltrand J, Le Gac I, Luton D, Polak M (2014) Management of neonates born to women with Graves\u2019 disease: a cohort study. Eur J Endocrinol 170: 855\u2013862.","DOI":"10.1530\/EJE-13-0994"},{"key":"14","doi-asserted-by":"publisher","unstructured":"15 \u00d6nsesveren I, Barjaktarovic M, Chaker L, de Rijke YB, Jaddoe VWV, et al. (2017) Childhood thyroid function reference ranges and determinants: a literature overview and a prospective cohort study. Thyroid 27: 1360\u20131369.","DOI":"10.1089\/thy.2017.0262"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Anckaert E, \u00d6ktem M, Thies A, Cohen-Bacrie M, Daan NM, et al. (2016) Multicenter analytical performance evaluation of a fully automated anti-M\u00fcllerian hormone assay and reference interval determination. Clin Biochem 49: 260\u2013267.","DOI":"10.1016\/j.clinbiochem.2015.10.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Vignati G, Chiecchio A, Osnaghi B, Giovanelli L, Meloncelli C (2008) Different biological matrices (serum and plasma) utilization in consolidation processes: evaluation of seven Access immunoassays. Clin Chem Lab Med 46: 264\u2013270.","DOI":"10.1515\/CCLM.2008.032"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Rezende VB, Amaral JH, Gerlach RF, Barbosa F Jr, Tanus-Santos JE (2010) Should we measure serum or plasma lead concentrations? J Trace Elem Med Biol 24: 147\u2013151.","DOI":"10.1016\/j.jtemb.2010.01.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Koch CD, Wockenfus AM, Saenger AK, J, Jaffe AS, Karon BS (2012) BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer. Clin Biochem 45: 842\u2013844.","DOI":"10.1016\/j.clinbiochem.2012.04.014"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Dimeski G (2011) Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method. Clin Chem Lab Med 49: 1079\u20131080.","DOI":"10.1515\/CCLM.2011.163"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Dimeski G, Masci PP, Trabi M, Lavin MF, de Jersey J (2010) Evaluation of the Becton\u2013Dickinson rapid serum tube: Does it provide a suitable alternative to lithium heparin plasma tubes? Clin Chem Lab Med 48: 651\u2013657.","DOI":"10.1515\/CCLM.2010.141"},{"key":"21","unstructured":"22 Hermsen D, Apple F, Garcia-Beltran L, Jaffe A, Karon B, et al. (2007) Results from a multicenter evaluation of the 4th generation elecsys troponin T assay. Clin Lab 53: 1\u20139."},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Kazmierczak SC, Sekhon H, Richards C (2005) False-positive troponin I measured with the Abbott Axsym attributed to fibrin interference. Int J Cardiol 101: 27\u201331.","DOI":"10.1016\/j.ijcard.2004.03.008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Yanagisawa Y, Isobe K, Naito A, Ishijima M, Nanmoku T, et al. (2017) Influence of <i>in vitro<\/i> hemolysis on 80 different laboratory tests. Clin Lab 63: 219\u2013226.","DOI":"10.7754\/Clin.Lab.2016.160305"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Lippi G, Giavarina D, Gelati M, Salvagno GL (2014) Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients. Clin Chim Acta 429: 143\u2013146.","DOI":"10.1016\/j.cca.2013.12.010"},{"key":"25","unstructured":"26 Wakui Y, Suzuki N, Uemichi F, Sakai H, Odawara M, et al. (2011) Basic and clinical evaluation of Elecsys anti-TSHR for thyrotropin receptor antibody (TRAb). Tokyo ika daigaku zasshi (Journal of Tokyo Medical University) 69: 382\u2013388 (In Japanese)."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/5\/65_EJ17-0426\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T12:32:00Z","timestamp":1570883520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/5\/65_EJ17-0426\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0426","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}